What those actions might be remain to be seen, but one course of action could be requiring an update to the labeling of these drugs, although more drastic measures or none at all arent out of the question, either
These criteria and collected variables were established to isolate the impact of GLP-1 prescriptions on study outcomes while controlling for potential confounding factors, with a specific focus on the risk of depression, anxiety, and suicide
"We were concerned about starting patients on the GLP-1s and not having the fulfillment ability three to six months down the line," Carroll said
Nutrition: Eat a balanced diet that includes plenty of fruits, vegetables, and whole grains
[6] Eli Lilly and Company, 'Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial', Investor press release, Dec